Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable our world-leading partners to advance their drug-screening capabilities for the development of game-changing medicines.
Company Details
- Employees
- 18
- Founded
- -
- Address
- Flöjelbergsgatan 8c, Mölndal,vastra Gotaland County 431 37,sweden
- Phone
- +46-762-08-33-54
- in****@****ell.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- fluicell.com
- Keywords
- Biotechnology, Bioprinting, Microfluidics, Biomedicine, Single-Cell Biology, Single-Cell Pharmacology, regenerative medicine, diabetes, cell therapy.
- HQ
- Mölndal, Vastra Gotaland County
Fluicell Questions
Fluicell's helpline number is +46-762-08-33-54
Fluicell's website is fluicell.com
Fluicell's LinkedIn profile is https://se.linkedin.com/company/fluicell-ab
Fluicell has
18 employees.
View email and phone details for 18
employees at Fluicell.
Fluicell's industry is
Biotechnology Research
Fluicell's top competitors are
Bio Inx,
Inventia Life Science,
Vivax Bio,
Vivosim Labs, Inc.,
Bico,
Cytena,
Tissuelabs,
Cellink,
Regenhu,
Cellectricon.
Fluicell's support email address is info@fluicell.com
Fluicell's categories are Biotechnology Research
Fluicell's founding year is 2012
